Please login to the form below

Not currently logged in
Email:
Password:

downsizing

This page shows the latest downsizing news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Lundbeck saw its share price more than triple due to his downsizing strategy, which included cutting around 1, 000 jobs.

Latest news

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Pharma deals in August 2015 Pharma deals in August 2015

    This revisit to oncology follows downsizing and reorganisation and moves Sanofi into next generation therapies which are anticipated to complement the current checkpoint inhibitors in development.

  • Pharma deals in April 2015 Pharma deals in April 2015

    Termination. As part of its ongoing re-prioritisation and trimming of its oncology pipeline and correspondingly downsizing and reorganising the R&D teams, Sanofi is terminating its agreement with ImmunoGen and

  • Interview: Ken Jones, Astellas Pharma Europe Interview: Ken Jones, Astellas Pharma Europe

    I am in a growth mode, while my competitors are going the other way and downsizing.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics